Cassava Sciences, Inc. (SAVA)

2.93 +0.13 (+4.64%) USD  |  NASDAQ  |  Dec 16, 16:00
2.93 0.00 (0.00%) Pre-Market: 08:19
More

Cassava Sciences Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for SAVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Biogen, Inc. Upgrade
Geron Corp. Upgrade
Ovid Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade